Delivery Order SPE2DB20D3103-SPE2DB24FP5C2

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMFKZ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,365.84 firm fixed-price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA5B1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,266.57 fixed-price delivery order is for the supply of 4567198595 - JANUVIA 100 MG TABLET 90S to support military healthcare programs. The contract has an ultimate completion date of February 10, 2025. No set-aside was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with the ID SPE2DB20D1110|SPE2DB24FK39U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the procurement of 4565221338 JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $7,628.24 and is a Firm Fixed Price Delivery Order type, with a completion date of July 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT4F8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, and has a ceiling value of $1,158.00. It is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is November 14, 2024. The contract does not have a set-aside designation, indicating an open...
This federal contract award SPE2DB20D2104|SPE2DB24FMBQH, valued at $14,844.45, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,565,828,567 units of the pharmaceutical product JANUVIA 100 MG TABLET 1000S. This contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP3J1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,511.57, is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of June 28, 2024. The contract does not have a set-aside designation, indicating it was awarded...
This federal contract award, with the ID SPE2DB20D2104|SPE2DB25FMCGH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $1,158.00. It is a Firm Fixed Price Delivery Order contract with a performance period ending on November 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, with ID SPE2DB20D1050|SPE2DB25FH54X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,347.16 firm fixed-price delivery order is for the supply of 4567617102 JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMMNB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,947.52, is for the delivery of JANUVIA 50 MG TABLET 90S. It is a firm fixed-price delivery order contract with an ultimate completion date of April 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, valued at $2,178.97, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The award has an ultimate completion date of April 26, 2023. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP5C2
    Delivery Order

This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP5C2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $8,416.46, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of 4565132103 - JANUVIA 100 MG TABLET 90S, a pharmaceutical product, with a performance period ending on July 15, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:16 AM